[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Procalcitonin Market Size, Manufacturers, Opportunities and Forecast to 2030

April 2024 | 119 pages | ID: G5BB248EC3D7EN
APO Research

US$ 3,450.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

Procalcitonin (PCT), CAS 56645-65-9, is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli

According to APO Research, The global Procalcitonin market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

North American market for Procalcitonin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Procalcitonin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Procalcitonin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Procalcitonin include Thermo Fisher, Roche Diagnostics, bioMerieux, HyTest, BBI Solutions, ProSpec, Wondfo, Ningbo Medicalsystem Biotechnology and Wuhan Easy Diagnosis Biomedicine, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Procalcitonin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Procalcitonin.

The Procalcitonin market size, estimations, and forecasts are provided in terms of sales volume (mg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Procalcitonin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
  • Thermo Fisher
  • Roche Diagnostics
  • bioMerieux
  • HyTest
  • BBI Solutions
  • ProSpec
  • Wondfo
  • Ningbo Medicalsystem Biotechnology
  • Wuhan Easy Diagnosis Biomedicine
  • Snibe
  • Vazyme Biotech
  • Getein Biotech
  • Hotgen Biotech
  • Lumigenex
  • Nanjing Norman Biological Technology
  • Kitgen
  • Beijing KeyGen
  • Beijing Apis
Procalcitonin segment by Type
  • Procalcitonin Antigen
  • Procalcitonin Antibody
Procalcitonin segment by Application
  • Medical Industry
  • Scientific Research
  • Veterinarian
Procalcitonin Segment by Region
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • China Taiwan
    • Indonesia
    • Thailand
    • Malaysia
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Procalcitonin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Procalcitonin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Procalcitonin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Procalcitonin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Procalcitonin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.
1 MARKET OVERVIEW

1.1 Product Definition
1.2 Global Market Growth Prospects
  1.2.1 Global Procalcitonin Market Size Estimates and Forecasts (2019-2030)
  1.2.2 Global Procalcitonin Sales Estimates and Forecasts (2019-2030)
1.3 Procalcitonin Market by Type
  1.3.1 Procalcitonin Antigen
  1.3.2 Procalcitonin Antibody
1.4 Global Procalcitonin Market Size by Type
  1.4.1 Global Procalcitonin Market Size Overview by Type (2019-2030)
  1.4.2 Global Procalcitonin Historic Market Size Review by Type (2019-2024)
  1.4.3 Global Procalcitonin Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
  1.5.1 North America Procalcitonin Sales Breakdown by Type (2019-2024)
  1.5.2 Europe Procalcitonin Sales Breakdown by Type (2019-2024)
  1.5.3 Asia-Pacific Procalcitonin Sales Breakdown by Type (2019-2024)
  1.5.4 Latin America Procalcitonin Sales Breakdown by Type (2019-2024)
  1.5.5 Middle East and Africa Procalcitonin Sales Breakdown by Type (2019-2024)

2 GLOBAL MARKET DYNAMICS

2.1 Procalcitonin Industry Trends
2.2 Procalcitonin Industry Drivers
2.3 Procalcitonin Industry Opportunities and Challenges
2.4 Procalcitonin Industry Restraints

3 MARKET COMPETITIVE LANDSCAPE BY COMPANY

3.1 Global Top Players by Procalcitonin Revenue (2019-2024)
3.2 Global Top Players by Procalcitonin Sales (2019-2024)
3.3 Global Top Players by Procalcitonin Price (2019-2024)
3.4 Global Procalcitonin Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Procalcitonin Key Company Manufacturing Sites & Headquarters
3.6 Global Procalcitonin Company, Product Type & Application
3.7 Global Procalcitonin Company Commercialization Time
3.8 Market Competitive Analysis
  3.8.1 Global Procalcitonin Market CR5 and HHI
  3.8.2 Global Top 5 and 10 Procalcitonin Players Market Share by Revenue in 2023
  3.8.3 2023 Procalcitonin Tier 1, Tier 2, and Tier

4 PROCALCITONIN REGIONAL STATUS AND OUTLOOK

4.1 Global Procalcitonin Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Procalcitonin Historic Market Size by Region
  4.2.1 Global Procalcitonin Sales in Volume by Region (2019-2024)
  4.2.2 Global Procalcitonin Sales in Value by Region (2019-2024)
  4.2.3 Global Procalcitonin Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Procalcitonin Forecasted Market Size by Region
  4.3.1 Global Procalcitonin Sales in Volume by Region (2025-2030)
  4.3.2 Global Procalcitonin Sales in Value by Region (2025-2030)
  4.3.3 Global Procalcitonin Sales (Volume & Value), Price and Gross Margin (2025-2030)

5 PROCALCITONIN BY APPLICATION

5.1 Procalcitonin Market by Application
  5.1.1 Medical Industry
  5.1.2 Scientific Research
  5.1.3 Veterinarian
5.2 Global Procalcitonin Market Size by Application
  5.2.1 Global Procalcitonin Market Size Overview by Application (2019-2030)
  5.2.2 Global Procalcitonin Historic Market Size Review by Application (2019-2024)
  5.2.3 Global Procalcitonin Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
  5.3.1 North America Procalcitonin Sales Breakdown by Application (2019-2024)
  5.3.2 Europe Procalcitonin Sales Breakdown by Application (2019-2024)
  5.3.3 Asia-Pacific Procalcitonin Sales Breakdown by Application (2019-2024)
  5.3.4 Latin America Procalcitonin Sales Breakdown by Application (2019-2024)
  5.3.5 Middle East and Africa Procalcitonin Sales Breakdown by Application (2019-2024)

6 COMPANY PROFILES

6.1 Thermo Fisher
  6.1.1 Thermo Fisher Comapny Information
  6.1.2 Thermo Fisher Business Overview
  6.1.3 Thermo Fisher Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
  6.1.4 Thermo Fisher Procalcitonin Product Portfolio
  6.1.5 Thermo Fisher Recent Developments
6.2 Roche Diagnostics
  6.2.1 Roche Diagnostics Comapny Information
  6.2.2 Roche Diagnostics Business Overview
  6.2.3 Roche Diagnostics Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
  6.2.4 Roche Diagnostics Procalcitonin Product Portfolio
  6.2.5 Roche Diagnostics Recent Developments
6.3 bioMerieux
  6.3.1 bioMerieux Comapny Information
  6.3.2 bioMerieux Business Overview
  6.3.3 bioMerieux Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
  6.3.4 bioMerieux Procalcitonin Product Portfolio
  6.3.5 bioMerieux Recent Developments
6.4 HyTest
  6.4.1 HyTest Comapny Information
  6.4.2 HyTest Business Overview
  6.4.3 HyTest Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
  6.4.4 HyTest Procalcitonin Product Portfolio
  6.4.5 HyTest Recent Developments
6.5 BBI Solutions
  6.5.1 BBI Solutions Comapny Information
  6.5.2 BBI Solutions Business Overview
  6.5.3 BBI Solutions Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
  6.5.4 BBI Solutions Procalcitonin Product Portfolio
  6.5.5 BBI Solutions Recent Developments
6.6 ProSpec
  6.6.1 ProSpec Comapny Information
  6.6.2 ProSpec Business Overview
  6.6.3 ProSpec Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
  6.6.4 ProSpec Procalcitonin Product Portfolio
  6.6.5 ProSpec Recent Developments
6.7 Wondfo
  6.7.1 Wondfo Comapny Information
  6.7.2 Wondfo Business Overview
  6.7.3 Wondfo Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
  6.7.4 Wondfo Procalcitonin Product Portfolio
  6.7.5 Wondfo Recent Developments
6.8 Ningbo Medicalsystem Biotechnology
  6.8.1 Ningbo Medicalsystem Biotechnology Comapny Information
  6.8.2 Ningbo Medicalsystem Biotechnology Business Overview
  6.8.3 Ningbo Medicalsystem Biotechnology Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
  6.8.4 Ningbo Medicalsystem Biotechnology Procalcitonin Product Portfolio
  6.8.5 Ningbo Medicalsystem Biotechnology Recent Developments
6.9 Wuhan Easy Diagnosis Biomedicine
  6.9.1 Wuhan Easy Diagnosis Biomedicine Comapny Information
  6.9.2 Wuhan Easy Diagnosis Biomedicine Business Overview
  6.9.3 Wuhan Easy Diagnosis Biomedicine Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
  6.9.4 Wuhan Easy Diagnosis Biomedicine Procalcitonin Product Portfolio
  6.9.5 Wuhan Easy Diagnosis Biomedicine Recent Developments
6.10 Snibe
  6.10.1 Snibe Comapny Information
  6.10.2 Snibe Business Overview
  6.10.3 Snibe Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
  6.10.4 Snibe Procalcitonin Product Portfolio
  6.10.5 Snibe Recent Developments
6.11 Vazyme Biotech
  6.11.1 Vazyme Biotech Comapny Information
  6.11.2 Vazyme Biotech Business Overview
  6.11.3 Vazyme Biotech Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
  6.11.4 Vazyme Biotech Procalcitonin Product Portfolio
  6.11.5 Vazyme Biotech Recent Developments
6.12 Getein Biotech
  6.12.1 Getein Biotech Comapny Information
  6.12.2 Getein Biotech Business Overview
  6.12.3 Getein Biotech Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
  6.12.4 Getein Biotech Procalcitonin Product Portfolio
  6.12.5 Getein Biotech Recent Developments
6.13 Hotgen Biotech
  6.13.1 Hotgen Biotech Comapny Information
  6.13.2 Hotgen Biotech Business Overview
  6.13.3 Hotgen Biotech Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
  6.13.4 Hotgen Biotech Procalcitonin Product Portfolio
  6.13.5 Hotgen Biotech Recent Developments
6.14 Lumigenex
  6.14.1 Lumigenex Comapny Information
  6.14.2 Lumigenex Business Overview
  6.14.3 Lumigenex Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
  6.14.4 Lumigenex Procalcitonin Product Portfolio
  6.14.5 Lumigenex Recent Developments
6.15 Nanjing Norman Biological Technology
  6.15.1 Nanjing Norman Biological Technology Comapny Information
  6.15.2 Nanjing Norman Biological Technology Business Overview
  6.15.3 Nanjing Norman Biological Technology Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
  6.15.4 Nanjing Norman Biological Technology Procalcitonin Product Portfolio
  6.15.5 Nanjing Norman Biological Technology Recent Developments
6.16 Kitgen
  6.16.1 Kitgen Comapny Information
  6.16.2 Kitgen Business Overview
  6.16.3 Kitgen Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
  6.16.4 Kitgen Procalcitonin Product Portfolio
  6.16.5 Kitgen Recent Developments
6.17 Beijing KeyGen
  6.17.1 Beijing KeyGen Comapny Information
  6.17.2 Beijing KeyGen Business Overview
  6.17.3 Beijing KeyGen Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
  6.17.4 Beijing KeyGen Procalcitonin Product Portfolio
  6.17.5 Beijing KeyGen Recent Developments
6.18 Beijing Apis
  6.18.1 Beijing Apis Comapny Information
  6.18.2 Beijing Apis Business Overview
  6.18.3 Beijing Apis Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
  6.18.4 Beijing Apis Procalcitonin Product Portfolio
  6.18.5 Beijing Apis Recent Developments

7 NORTH AMERICA BY COUNTRY

7.1 North America Procalcitonin Sales by Country
  7.1.1 North America Procalcitonin Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
  7.1.2 North America Procalcitonin Sales by Country (2019-2024)
  7.1.3 North America Procalcitonin Sales Forecast by Country (2025-2030)
7.2 North America Procalcitonin Market Size by Country
  7.2.1 North America Procalcitonin Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
  7.2.2 North America Procalcitonin Market Size by Country (2019-2024)
  7.2.3 North America Procalcitonin Market Size Forecast by Country (2025-2030)

8 EUROPE BY COUNTRY

8.1 Europe Procalcitonin Sales by Country
  8.1.1 Europe Procalcitonin Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
  8.1.2 Europe Procalcitonin Sales by Country (2019-2024)
  8.1.3 Europe Procalcitonin Sales Forecast by Country (2025-2030)
8.2 Europe Procalcitonin Market Size by Country
  8.2.1 Europe Procalcitonin Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
  8.2.2 Europe Procalcitonin Market Size by Country (2019-2024)
  8.2.3 Europe Procalcitonin Market Size Forecast by Country (2025-2030)

9 ASIA-PACIFIC BY COUNTRY

9.1 Asia-Pacific Procalcitonin Sales by Country
  9.1.1 Asia-Pacific Procalcitonin Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
  9.1.2 Asia-Pacific Procalcitonin Sales by Country (2019-2024)
  9.1.3 Asia-Pacific Procalcitonin Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Procalcitonin Market Size by Country
  9.2.1 Asia-Pacific Procalcitonin Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
  9.2.2 Asia-Pacific Procalcitonin Market Size by Country (2019-2024)
  9.2.3 Asia-Pacific Procalcitonin Market Size Forecast by Country (2025-2030)

10 LATIN AMERICA BY COUNTRY

10.1 Latin America Procalcitonin Sales by Country
  10.1.1 Latin America Procalcitonin Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
  10.1.2 Latin America Procalcitonin Sales by Country (2019-2024)
  10.1.3 Latin America Procalcitonin Sales Forecast by Country (2025-2030)
10.2 Latin America Procalcitonin Market Size by Country
  10.2.1 Latin America Procalcitonin Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
  10.2.2 Latin America Procalcitonin Market Size by Country (2019-2024)
  10.2.3 Latin America Procalcitonin Market Size Forecast by Country (2025-2030)

11 MIDDLE EAST AND AFRICA BY COUNTRY

11.1 Middle East and Africa Procalcitonin Sales by Country
  11.1.1 Middle East and Africa Procalcitonin Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
  11.1.2 Middle East and Africa Procalcitonin Sales by Country (2019-2024)
  11.1.3 Middle East and Africa Procalcitonin Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Procalcitonin Market Size by Country
  11.2.1 Middle East and Africa Procalcitonin Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
  11.2.2 Middle East and Africa Procalcitonin Market Size by Country (2019-2024)
  11.2.3 Middle East and Africa Procalcitonin Market Size Forecast by Country (2025-2030)

12 VALUE CHAIN AND SALES CHANNELS ANALYSIS

12.1 Procalcitonin Value Chain Analysis
  12.1.1 Procalcitonin Key Raw Materials
  12.1.2 Key Raw Materials Price
  12.1.3 Raw Materials Key Suppliers
  12.1.4 Manufacturing Cost Structure
  12.1.5 Procalcitonin Production Mode & Process
12.2 Procalcitonin Sales Channels Analysis
  12.2.1 Direct Comparison with Distribution Share
  12.2.2 Procalcitonin Distributors
  12.2.3 Procalcitonin Customers

13 CONCLUDING INSIGHTS

14 APPENDIX

14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
  14.5.1 Secondary Sources
  14.5.2 Primary Sources
14.6 Disclaimer
LIST OF TABLES

Table 1. Major Company of Procalcitonin Antigen
Table 2. Major Company of Procalcitonin Antibody
Table 3. Global Procalcitonin Sales by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 4. Global Procalcitonin Sales by Type (2019-2024) & (mg)
Table 5. Global Procalcitonin Sales Market Share in Volume by Type (2019-2024)
Table 6. Global Procalcitonin Sales by Type (2019-2024) & (US$ Million)
Table 7. Global Procalcitonin Sales Market Share in Value by Type (2019-2024)
Table 8. Global Procalcitonin Price by Type (2019-2024) & (USD/mg)
Table 9. Global Procalcitonin Sales by Type (2025-2030) & (mg)
Table 10. Global Procalcitonin Sales Market Share in Volume by Type (2025-2030)
Table 11. Global Procalcitonin Sales by Type (2025-2030) & (US$ Million)
Table 12. Global Procalcitonin Sales Market Share in Value by Type (2025-2030)
Table 13. Global Procalcitonin Price by Type (2025-2030) & (USD/mg)
Table 14. North America Procalcitonin Sales by Type (2019-2024) & (mg)
Table 15. North America Procalcitonin Sales by Type (2019-2024) & (US$ Million)
Table 16. Europe Procalcitonin Sales by Type (2019-2024) & (mg)
Table 17. Europe Procalcitonin Sales by Type (2019-2024) & (US$ Million)
Table 18. Asia-Pacific Procalcitonin Sales by Type (2019-2024) & (mg)
Table 19. Asia-Pacific Procalcitonin Sales by Type (2019-2024) & (US$ Million)
Table 20. Latin America Procalcitonin Sales by Type (2019-2024) & (mg)
Table 21. Latin America Procalcitonin Sales by Type (2019-2024) & (US$ Million)
Table 22. Middle East and Africa Procalcitonin Sales by Type (2019-2024) & (mg)
Table 23. Middle East and Africa Procalcitonin Sales by Type (2019-2024) & (US$ Million)
Table 24. Procalcitonin Industry Trends
Table 25. Procalcitonin Industry Drivers
Table 26. Procalcitonin Industry Opportunities and Challenges
Table 27. Procalcitonin Industry Restraints
Table 28. Global Procalcitonin Sales Revenue by Company (US$ Million) & (2019-2024)
Table 29. Global Procalcitonin Revenue Market Share by Company (2019-2024)
Table 30. Global Procalcitonin Sales by Company (2019-2024) & (mg)
Table 31. Global Procalcitonin Sales Share by Company (2019-2024)
Table 32. Global Procalcitonin Market Price by Company (2019-2024) & (USD/mg)
Table 33. Global Procalcitonin Industry Company Ranking, 2022 VS 2023 VS 2024
Table 34. Global Procalcitonin Key Company Manufacturing Sites & Headquarters
Table 35. Global Procalcitonin Company, Product Type & Application
Table 36. Global Procalcitonin Company Commercialization Time
Table 37. Global Company Market Concentration Ratio (CR5 and HHI)
Table 38. Global Procalcitonin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 39. Global Procalcitonin Market Size Comparison by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Global Procalcitonin Sales by Region (2019-2024) & (mg)
Table 41. Global Procalcitonin Sales Market Share in Volume by Region (2019-2024)
Table 42. Global Procalcitonin Sales by Region (2019-2024) & (US$ Million)
Table 43. Global Procalcitonin Sales Market Share in Value by Region (2019-2024)
Table 44. Global Procalcitonin Sales (mg), Value (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 45. Global Procalcitonin Sales by Region (2025-2030) & (mg)
Table 46. Global Procalcitonin Sales Market Share in Volume by Region (2025-2030)
Table 47. Global Procalcitonin Sales by Region (2025-2030) & (US$ Million)
Table 48. Global Procalcitonin Sales Market Share in Value by Region (2025-2030)
Table 49. Global Procalcitonin Sales (mg), Value (US$ Million), Price (USD/mg) and Gross Margin (2025-2030)
Table 50. Global Procalcitonin Sales by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 51. Global Procalcitonin Sales by Application (2019-2024) & (mg)
Table 52. Global Procalcitonin Sales Market Share in Volume by Application (2019-2024)
Table 53. Global Procalcitonin Sales by Application (2019-2024) & (US$ Million)
Table 54. Global Procalcitonin Sales Market Share in Value by Application (2019-2024)
Table 55. Global Procalcitonin Price by Application (2019-2024) & (USD/mg)
Table 56. Global Procalcitonin Sales by Application (2025-2030) & (mg)
Table 57. Global Procalcitonin Sales Market Share in Volume by Application (2025-2030)
Table 58. Global Procalcitonin Sales by Application (2025-2030) & (US$ Million)
Table 59. Global Procalcitonin Sales Market Share in Value by Application (2025-2030)
Table 60. Global Procalcitonin Price by Application (2025-2030) & (USD/mg)
Table 61. North America Procalcitonin Sales by Application (2019-2024) & (mg)
Table 62. North America Procalcitonin Sales by Application (2019-2024) & (US$ Million)
Table 63. Europe Procalcitonin Sales by Application (2019-2024) & (mg)
Table 64. Europe Procalcitonin Sales by Application (2019-2024) & (US$ Million)
Table 65. Asia-Pacific Procalcitonin Sales by Application (2019-2024) & (mg)
Table 66. Asia-Pacific Procalcitonin Sales by Application (2019-2024) & (US$ Million)
Table 67. Latin America Procalcitonin Sales by Application (2019-2024) & (mg)
Table 68. Latin America Procalcitonin Sales by Application (2019-2024) & (US$ Million)
Table 69. Middle East and Africa Procalcitonin Sales by Application (2019-2024) & (mg)
Table 70. Middle East and Africa Procalcitonin Sales by Application (2019-2024) & (US$ Million)
Table 71. Thermo Fisher Company Information
Table 72. Thermo Fisher Business Overview
Table 73. Thermo Fisher Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 74. Thermo Fisher Procalcitonin Product Portfolio
Table 75. Thermo Fisher Recent Development
Table 76. Roche Diagnostics Company Information
Table 77. Roche Diagnostics Business Overview
Table 78. Roche Diagnostics Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 79. Roche Diagnostics Procalcitonin Product Portfolio
Table 80. Roche Diagnostics Recent Development
Table 81. bioMerieux Company Information
Table 82. bioMerieux Business Overview
Table 83. bioMerieux Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 84. bioMerieux Procalcitonin Product Portfolio
Table 85. bioMerieux Recent Development
Table 86. HyTest Company Information
Table 87. HyTest Business Overview
Table 88. HyTest Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 89. HyTest Procalcitonin Product Portfolio
Table 90. HyTest Recent Development
Table 91. BBI Solutions Company Information
Table 92. BBI Solutions Business Overview
Table 93. BBI Solutions Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 94. BBI Solutions Procalcitonin Product Portfolio
Table 95. BBI Solutions Recent Development
Table 96. ProSpec Company Information
Table 97. ProSpec Business Overview
Table 98. ProSpec Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 99. ProSpec Procalcitonin Product Portfolio
Table 100. ProSpec Recent Development
Table 101. Wondfo Company Information
Table 102. Wondfo Business Overview
Table 103. Wondfo Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 104. Wondfo Procalcitonin Product Portfolio
Table 105. Wondfo Recent Development
Table 106. Ningbo Medicalsystem Biotechnology Company Information
Table 107. Ningbo Medicalsystem Biotechnology Business Overview
Table 108. Ningbo Medicalsystem Biotechnology Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 109. Ningbo Medicalsystem Biotechnology Procalcitonin Product Portfolio
Table 110. Ningbo Medicalsystem Biotechnology Recent Development
Table 111. Wuhan Easy Diagnosis Biomedicine Company Information
Table 112. Wuhan Easy Diagnosis Biomedicine Business Overview
Table 113. Wuhan Easy Diagnosis Biomedicine Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 114. Wuhan Easy Diagnosis Biomedicine Procalcitonin Product Portfolio
Table 115. Wuhan Easy Diagnosis Biomedicine Recent Development
Table 116. Snibe Company Information
Table 117. Snibe Business Overview
Table 118. Snibe Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 119. Snibe Procalcitonin Product Portfolio
Table 120. Snibe Recent Development
Table 121. Vazyme Biotech Company Information
Table 122. Vazyme Biotech Business Overview
Table 123. Vazyme Biotech Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 124. Vazyme Biotech Procalcitonin Product Portfolio
Table 125. Vazyme Biotech Recent Development
Table 126. Getein Biotech Company Information
Table 127. Getein Biotech Business Overview
Table 128. Getein Biotech Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 129. Getein Biotech Procalcitonin Product Portfolio
Table 130. Getein Biotech Recent Development
Table 131. Hotgen Biotech Company Information
Table 132. Hotgen Biotech Business Overview
Table 133. Hotgen Biotech Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 134. Hotgen Biotech Procalcitonin Product Portfolio
Table 135. Hotgen Biotech Recent Development
Table 136. Lumigenex Company Information
Table 137. Lumigenex Business Overview
Table 138. Lumigenex Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 139. Lumigenex Procalcitonin Product Portfolio
Table 140. Lumigenex Recent Development
Table 141. Nanjing Norman Biological Technology Company Information
Table 142. Nanjing Norman Biological Technology Business Overview
Table 143. Nanjing Norman Biological Technology Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 144. Nanjing Norman Biological Technology Procalcitonin Product Portfolio
Table 145. Nanjing Norman Biological Technology Recent Development
Table 146. Kitgen Company Information
Table 147. Kitgen Business Overview
Table 148. Kitgen Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 149. Kitgen Procalcitonin Product Portfolio
Table 150. Kitgen Recent Development
Table 151. Beijing KeyGen Company Information
Table 152. Beijing KeyGen Business Overview
Table 153. Beijing KeyGen Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 154. Beijing KeyGen Procalcitonin Product Portfolio
Table 155. Beijing KeyGen Recent Development
Table 156. Beijing Apis Company Information
Table 157. Beijing Apis Business Overview
Table 158. Beijing Apis Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 159. Beijing Apis Procalcitonin Product Portfolio
Table 160. Beijing Apis Recent Development
Table 161. North America Procalcitonin Market Size Growth Rate (CAGR) by Country (mg): 2019 VS 2023 VS 2030
Table 162. North America Procalcitonin Sales by Country (2019-2024) & (mg)
Table 163. North America Procalcitonin Sales Market Share by Country (2019-2024)
Table 164. North America Procalcitonin Sales Forecast by Country (2025-2030) & (mg)
Table 165. North America Procalcitonin Sales Market Share Forecast by Country (2025-2030)
Table 166. North America Procalcitonin Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 167. North America Procalcitonin Market Size by Country (2019-2024) & (US$ Million)
Table 168. North America Procalcitonin Market Share by Country (2019-2024)
Table 169. North America Procalcitonin Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 170. North America Procalcitonin Market Share Forecast by Country (2025-2030)
Table 171. Europe Procalcitonin Market Size Growth Rate (CAGR) by Country (mg): 2019 VS 2023 VS 2030
Table 172. Europe Procalcitonin Sales by Country (2019-2024) & (mg)
Table 173. Europe Procalcitonin Sales Market Share by Country (2019-2024)
Table 174. Europe Procalcitonin Sales Forecast by Country (2025-2030) & (mg)
Table 175. Europe Procalcitonin Sales Market Share Forecast by Country (2025-2030)
Table 176. Europe Procalcitonin Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 177. Europe Procalcitonin Market Size by Country (2019-2024) & (US$ Million)
Table 178. Europe Procalcitonin Market Share by Country (2019-2024)
Table 179. Europe Procalcitonin Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 180. Europe Procalcitonin Market Share Forecast by Country (2025-2030)
Table 181. Asia-Pacific Procalcitonin Market Size Growth Rate (CAGR) by Country (mg): 2019 VS 2023 VS 2030
Table 182. Asia-Pacific Procalcitonin Sales by Country (2019-2024) & (mg)
Table 183. Asia-Pacific Procalcitonin Sales Market Share by Country (2019-2024)
Table 184. Asia-Pacific Procalcitonin Sales Forecast by Country (2025-2030) & (mg)
Table 185. Asia-Pacific Procalcitonin Sales Market Share Forecast by Country (2025-2030)
Table 186. Asia-Pacific Procalcitonin Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 187. Asia-Pacific Procalcitonin Market Size by Country (2019-2024) & (US$ Million)
Table 188. Asia-Pacific Procalcitonin Market Share by Country (2019-2024)
Table 189. Asia-Pacific Procalcitonin Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 190. Asia-Pacific Procalcitonin Market Share Forecast by Country (2025-2030)
Table 191. Latin America Procalcitonin Market Size Growth Rate (CAGR) by Country (mg): 2019 VS 2023 VS 2030
Table 192. Latin America Procalcitonin Sales by Country (2019-2024) & (mg)
Table 193. Latin America Procalcitonin Sales Market Share by Country (2019-2024)
Table 194. Latin America Procalcitonin Sales Forecast by Country (2025-2030) & (mg)
Table 195. Latin America Procalcitonin Sales Market Share Forecast by Country (2025-2030)
Table 196. Latin America Procalcitonin Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 197. Latin America Procalcitonin Market Size by Country (2019-2024) & (US$ Million)
Table 198. Latin America Procalcitonin Market Share by Country (2019-2024)
Table 199. Latin America Procalcitonin Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 200. Latin America Procalcitonin Market Share Forecast by Country (2025-2030)
Table 201. Middle East and Africa Procalcitonin Market Size Growth Rate (CAGR) by Country (mg): 2019 VS 2023 VS 2030
Table 202. Middle East and Africa Procalcitonin Sales by Country (2019-2024) & (mg)
Table 203. Middle East and Africa Procalcitonin Sales Market Share by Country (2019-2024)
Table 204. Middle East and Africa Procalcitonin Sales Forecast by Country (2025-2030) & (mg)
Table 205. Middle East and Africa Procalcitonin Sales Market Share Forecast by Country (2025-2030)
Table 206. Middle East and Africa Procalcitonin Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 207. Middle East and Africa Procalcitonin Market Size by Country (2019-2024) & (US$ Million)
Table 208. Middle East and Africa Procalcitonin Market Share by Country (2019-2024)
Table 209. Middle East and Africa Procalcitonin Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 210. Middle East and Africa Procalcitonin Market Share Forecast by Country (2025-2030)
Table 211. Key Raw Materials
Table 212. Raw Materials Key Suppliers
Table 213. Procalcitonin Distributors List
Table 214. Procalcitonin Customers List
Table 215. Research Programs/Design for This Report
Table 216. Authors List of This Report
Table 217. Secondary Sources
Table 218. Primary Sources

LIST OF FIGURES

Figure 1. Procalcitonin Product Picture
Figure 2. Global Procalcitonin Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Procalcitonin Market Size (2019-2030) & (US$ Million)
Figure 4. Global Procalcitonin Sales (2019-2030) & (mg)
Figure 5. Product Picture of Procalcitonin Antigen
Figure 6. Global Procalcitonin Antigen Sales YoY Growth (2019-2030) & (mg)
Figure 7. Product Picture of Procalcitonin Antibody
Figure 8. Global Procalcitonin Antibody Sales YoY Growth (2019-2030) & (mg)
Figure 9. Global Procalcitonin Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 10. Global Procalcitonin Market Share by Type 2023 VS 2030
Figure 11. North America Procalcitonin Sales Market Share in Volume by Type in 2023
Figure 12. North America Procalcitonin Sales Market Share in Value by Type in 2023
Figure 13. Europe Procalcitonin Sales Market Share in Volume by Type in 2023
Figure 14. Europe Procalcitonin Sales Market Share in Value by Type in 2023
Figure 15. Asia-Pacific Procalcitonin Sales Market Share in Volume by Type in 2023
Figure 16. Asia-Pacific Procalcitonin Sales Market Share in Value by Type in 2023
Figure 17. Latin America Procalcitonin Sales Market Share in Volume by Type in 2023
Figure 18. Latin America Procalcitonin Sales Market Share in Value by Type in 2023
Figure 19. Middle East and Africa Procalcitonin Sales Market Share in Volume by Type in 2023
Figure 20. Middle East and Africa Procalcitonin Sales Market Share in Value by Type in 2023
Figure 21. Global Top 5 and 10 Procalcitonin Players Market Share by Revenue in 2023
Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 23. Product Picture of Medical Industry
Figure 24. Global Medical Industry Sales YoY Growth (2019-2030) & (mg)
Figure 25. Product Picture of Scientific Research
Figure 26. Global Scientific Research Sales YoY Growth (2019-2030) & (mg)
Figure 27. Product Picture of Veterinarian
Figure 28. Global Veterinarian Sales YoY Growth (2019-2030) & (mg)
Figure 29. Global Procalcitonin Market Size Overview by Applicatio


More Publications